Dr. Chirag Desai MBBS , MD (Medicine), DM (Oncology), DNB
Hemato-Oncology Clinic (HOC) Vedanta
32 Years Experience
Dr. Chirag Desai – Hemato Oncologist
MBBS, MD (Medicine), DM (Oncology), DNB
Professional Summary
Dr. Chirag J. Desai is Founder Director of Hemato-Oncology Clinic (HOC) Vedanta, Ahmedabad, with 32+ years as a leading Hemato-Oncologist specializing in blood cancers and solid tumors. First-batch DM (Oncology) graduate from GCRI (1993), he has led 75+ clinical trials, published 30+ papers, and advanced oncology protocols across India. Renowned for research-driven care, multidisciplinary tumor boards, and cancer awareness initiatives.[web:1][file:79]
Hospital Affiliation
Hemato-Oncology Clinic (HOC) Vedanta, Ahmedabad
Founder Director & Chief Consultant Hemato-Oncologist
- State-of-the-art oncology/hematology facilities with advanced chemotherapy
- Comprehensive tumor boards and clinical trial capabilities
- Research-oriented treatment protocols and immunotherapy services
Specialization Areas
Hemato-Oncology (Blood Cancers)
- Leukemias: AML, ALL, CML, CLL, hairy cell leukemia
- Lymphomas: Hodgkin, NHL, lymphoblastic, T/B-cell, CNS lymphoma
- Plasma cell disorders: multiple myeloma, Waldenström, amyloidosis
- MDS, aplastic anemia, myeloproliferative neoplasms, TTP
Solid Tumor Oncology
- Breast: triple-negative, HER2+, hormone-positive, neoadjuvant/adjuvant
- Gynecological: ovarian, cervical, endometrial, vulvar cancers
- Prostate: localized, metastatic, CRPC management
- Head & neck, lung (SCLC/NSCLC, EGFR/ALK), GI cancers (gastric, colorectal)
Advanced Cancer Therapies
- Chemotherapy (conventional/novel), targeted therapy, immunotherapy
- Checkpoint inhibitors, combination protocols, tumor lysis management
- Supportive/palliative oncology with symptom control
Clinical Research & Academic Excellence
- Principal investigator in 75+ USFDA/EMEA trials, DSMB member
- 30+ publications, editorial boards, thesis mentor for 35+ students
- Invited faculty at major oncology conferences, CDSCO expert presenter
- Former National Oncology Coordinator, Director at Apollo CBCC
Treatment Philosophy
- Evidence-Based Protocols – latest international cancer guidelines
- Personalized Medicine – molecular profiling and targeted selection
- Multidisciplinary Care – tumor boards with surgeons/radiation oncologists
- Clinical Trial Access – early-phase and registration studies
- Community Education – prevention, early detection programs
Advanced Services
- Cancer Diagnosis: Tumor profiling, genetic testing, biomarker analysis
- Treatment Planning: Multidisciplinary tumor boards, risk stratification
- Clinical Trials: Phase I-III, biosimilars, immunotherapy, vaccines
- Supportive Care: Nutrition, pain management, psychological support
Support Services
- Advanced chemotherapy/immunotherapy administration
- Nutritional counseling, palliative care coordination
- Cancer survivorship programs, second opinions
- Community awareness and clinical trial enrollment
Reopine Consultation Details
Available Services:
- ✅ First Opinion Consultations – Cancer diagnosis/treatment planning
- ✅ Second Opinion Reviews – Complex hemato-oncology assessment
- ✅ Blood Cancer Consultations – Leukemia/lymphoma management
- ✅ Solid Tumor Planning – Breast/prostate/GI strategies
- ✅ Clinical Trial Information – Latest oncology research access
- ✅ Palliative Care Planning – Advanced cancer support
Languages Spoken:
- English (Fluent)
- Hindi (Fluent)
- Gujarati (Native)
Book Your Consultation
Access world-class cancer care from India's leading hemato-oncologist with 32+ years experience. Dr. Chirag Desai offers expert consultations through Reopine's secure platform for blood cancers, solid tumors, and clinical trial opportunities. Request today for evidence-based oncology expertise and personalized treatment strategies.
Last Updated: November 2025
Profile prepared for Reopine
Date: 15 Feb 2026
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 15 Feb 2026
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.